Media

House passes NDAA with Kelly amendment to ban funding for Obama-era arms control treaty

WATCH HERE

WASHINGTON — U.S. Representative Mike Kelly (R-PA) – a member of the House Ways and Means Committee – issued the following statement today after introducing the Invent and Manufacture in America Act (H.R. 3068) in the House of Representatives. This legislation would provide a tax credit for companies that not only conduct research & development (R&D) in the United States but domestically manufacture products resulting from said R&D as well. The bill is co-sponsored by Rep.

WASHINGTON — U.S. Representative Mike Kelly (R-PA) issued the following statement today regarding the unanimous decision by the U.S. Supreme Court to reinstate most of President Trump’s travel ban, first introduced via executive order in January and revised in March.

WASHINGTON — U.S. Representative Mike Kelly (R-PA) issued the following statement today regarding this morning’s shooting in Alexandria, Virginia.

Second tele-town hall of the year to enable thousands of constituents to get answers and make voices heard

WASHINGTON — U.S. Representative Mike Kelly (PA-03) announced today that he will host a toll-free telephone town hall meeting next week for constituents of the Third District to ask questions and receive answers regarding current events and issues of general concern.

WHAT: A free tele-town hall hosted by Rep. Kelly to discuss general issues

Kelly introduced resolution with Sen. Mike Lee in 2015 to require that accord be sent to US Senate for ratification

WASHINGTON — U.S.

Tax relief legislation endorsed by major child advocacy groups

WASHINGTON — U.S. Representative Mike Kelly (R-PA) – a member of the House Ways and Means Committee – issued the following statement today after introducing the Working Families Relief Act (H.R. 2618) in the House of Representatives.

Legislation tackles leading driver of health care costs

WASHINGTON — U.S. Representative Mike Kelly (R-PA) – a member of the House Ways and Means Committee – released the following statement today after introducing H.R. 2562, the Making Pharmaceutical Markets More Competitive Act, in the House of Representatives.